jueves, 10 de septiembre de 2026
Fintepla Effectiveness and Safety in Patients With Lennox-Gastaut Syndrome by Madaline Spencer| Published on: Sep 10, 2026
Fintepla Effectiveness and Safety in Patients With Lennox-Gastaut Syndrome
by Madaline Spencer| Published on: Sep 10, 2026
Amélie Lothe, PhD, Head of Global Medical Community of Rare Epilepsies at UCB, discusses results from a post hoc analysis of trajectories of Fintepla (fenfluramine) effectiveness and safety in patients with Lennox-Gastaut syndrome (LGS).
https://checkrare.com/fintepla-effectiveness-and-safety-in-patients-with-lennox-gastaut-syndrome/
Suscribirse a:
Enviar comentarios (Atom)


No hay comentarios:
Publicar un comentario